tiprankstipranks
Trending News
More News >

Jiangzhong Pharmaceutical Reports 2024 Financial Results with Increased Profits

Story Highlights
Jiangzhong Pharmaceutical Reports 2024 Financial Results with Increased Profits

Don’t Miss TipRanks’ Half-Year Sale

China Resources Pharmaceutical Group Ltd. ( (HK:3320) ) has shared an update.

Jiangzhong Pharmaceutical, a subsidiary of China Resources Pharmaceutical Group Ltd., reported its financial results for the year ended December 31, 2024. The company experienced a slight increase in total assets by 1.66% but faced a decrease in revenue by 2.59%. However, it achieved a notable increase in net profit attributable to shareholders by 9.67%. The board proposed a cash dividend distribution, pending shareholder approval, reflecting a positive outlook despite challenges in revenue growth.

More about China Resources Pharmaceutical Group Ltd.

China Resources Pharmaceutical Group Ltd. is a major player in the pharmaceutical industry, focusing on the development, manufacturing, and distribution of pharmaceutical products. The company holds a significant equity interest in Jiangzhong Pharmaceutical, a company listed on the Shanghai Stock Exchange, and operates through its subsidiary, China Resources Jiangzhong Pharmaceutical Group Co., Ltd.

YTD Price Performance: -5.88%

Average Trading Volume: 2,135

Technical Sentiment Consensus Rating: Sell

Current Market Cap: €4.2B

Find detailed analytics on 3320 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1